John Hadden serves as Executive at PLx Pharma Inc., where they oversee executive responsibilities. Since joining the company, John Hadden has executed 4 insider transactions totaling $8.2K, demonstrating a bullish approach to their equity position. Their most recent transaction on Dec 14, 2020 involved purchasing 400 shares valued at $2.2K.
John Hadden currently holds 3,690 shares of PLx Pharma Inc. (PLXP), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, John Hadden has been a net buyer of PLXP stock. They have purchased $8.2K and sold $0 worth of shares.
John Hadden's most recent insider trade was on Dec 14, 2020, when they purchased 400 shares at $5.49 per share.
Get notified when new Form 4 filings are submitted
| $5.42 |
| Discretionary |
| Nov 25, 2020 | PLXP | $2.7K | Purchase | 500 | $5.48 | Discretionary |
| Apr 19, 2017 | PLXP | $0 | Award | 2,190 | $N/A | Discretionary |